Does exenatide reduce liver fat content and epicardial adipose tissue in obese patients with type 2 diabetes?
Exenatide reduces liver and epicardial fat in obese patients with type 2 diabetes, primarily driven by weight loss.
Our data indicate that exenatide is an effective treatment to reduce liver fat content and epicardial fat in obese patients with type 2 diabetes, and these effects are mainly weight loss dependent.
Dutour et al. (Sat,) studied this question.